These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Evaluation of cardiac sympathetic innervation with iodine-123-metaiodobenzylguanidine imaging in silent myocardial ischemia. Matsuo S; Takahashi M; Nakamura Y; Kinoshita M J Nucl Med; 1996 May; 37(5):712-7. PubMed ID: 8965132 [TBL] [Abstract][Full Text] [Related]
5. A novel method for the assessment of autonomic neuropathy in type 2 diabetic patients: a comparative evaluation of 123I-MIBG myocardial scintigraphy and power spectral analysis of heart rate variability. Murata K; Sumida Y; Murashima S; Matsumura K; Takeda H; Nakagawa T; Shima T Diabet Med; 1996 Mar; 13(3):266-72. PubMed ID: 8689849 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy. Langen KJ; Ziegler D; Weise F; Piolot R; Boy C; Hübinger A; Gries FA; Müller-Gärtner HW Clin Sci (Lond); 1997 Oct; 93(4):325-33. PubMed ID: 9404224 [TBL] [Abstract][Full Text] [Related]
7. Measurement of myocardial accumulation of 123I-metaiodobenzylguanidine for studying cardiac autonomic neuropathy in diabetes mellitus. Mäntysaari M; Kuikka J; Mustonen J; Tahvanainen K; Vanninen E; Länsimies E; Uusitupa M Clin Auton Res; 1996 Jun; 6(3):163-9. PubMed ID: 8832126 [TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of 123I-metaiodobenzylguanidine myocardial scintigraphy in diabetic patients with cardiac sympathetic nerve dysfunction. Miyanaga H; Yoneyama S; Kamitani T; Kawasaki S; Takahashi T; Kunishige H Jpn Circ J; 1995 Sep; 59(9):599-607. PubMed ID: 7500543 [TBL] [Abstract][Full Text] [Related]
10. [Usefulness of myocardial imaging by 123I-MIBG in assessment of diabetic neuropathy]. Katono E; Owada K; Takeda H; Techigawara M; Watanabe N; Maruyama Y Kaku Igaku; 1993 Oct; 30(10):1235-9. PubMed ID: 8264114 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of cardiac sympathetic neuronal integrity in diabetic patients using iodine-123 metaiodobenzylguanidine. Kim SJ; Lee JD; Ryu YH; Jeon P; Shim YW; Yoo HS; Park CY; Lim SG Eur J Nucl Med; 1996 Apr; 23(4):401-6. PubMed ID: 8612660 [TBL] [Abstract][Full Text] [Related]
12. [Quantitative analysis of 123I-metaiodobenzylguanidine myocardial imaging: assessment of its usefulness in patients with congestive heart failure]. Narita M; Kurihara T; Murano K; Usami M; Honda M Kaku Igaku; 1994 Apr; 31(4):347-58. PubMed ID: 8196231 [TBL] [Abstract][Full Text] [Related]
14. Use of iodine-123 metaiodobenzylguanidine scintigraphy to assess cardiac sympathetic denervation and the impact of hypertension in patients with non-insulin-dependent diabetes mellitus. Tamura K; Utsunomiya K; Nakatani Y; Saika Y; Onishi S; Iwasaka T Eur J Nucl Med; 1999 Oct; 26(10):1310-6. PubMed ID: 10541830 [TBL] [Abstract][Full Text] [Related]
15. Scintigraphic assessment of silent myocardial ischaemia after early infarction using myocardial SPET imaging with 201Tl and 123I-MIBG. Shimonagata T; Ishida Y; Hayashida K; Takamiya M; Uehara T; Nishimura T Nucl Med Commun; 1995 Nov; 16(11):893-900. PubMed ID: 8587753 [TBL] [Abstract][Full Text] [Related]